Navigation Links
HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
Date:12/20/2007

Health care license revenue increases more than 100% in third quarter

ANN ARBOR, Mich., Dec. 20 /PRNewswire/ -- HealthMedia, the global leader in scalable behavior change interventions with outcomes, secured several new partnerships and continued to experience rapid growth throughout the third quarter of 2007. The company also introduced enhancements to its HealthMedia Connect(TM) product and was honored for its leadership and innovation.

HealthMedia's health care license revenue in the third quarter of 2007 increased more than 100 percent from the same quarter in 2006. The company also experienced its highest earnings for any single quarter since its inception in 1998.

"HealthMedia's growth continues to be driven by product enhancements, new partnerships, and expansion of existing relationships," explained Ted Dacko, HealthMedia President and CEO. "HealthMedia's scalable, results-driven programs are increasingly valuable to employers and health plans seeking meaningful and proven ways to reduce medical costs, improve productivity, and increase overall health. As more and more populations turn to the Web for ways to manage and improve health, the HealthMedia revolution continues to gain traction."

Product Enhancements Support HealthMedia's Value to Customers

The introduction of HealthMedia Connect(TM) enables HealthMedia to provide its customers a comprehensive solution that facilitates connections with end users, including employees and health plan members. HealthMedia Connect enhancements, designed to drive maximum participation and ensure return on investment, include tailored intelligent recruitment methods and additional incentive management options.

HealthMedia Results(TM), an innovative package of products and services, helps customers better understand their populations and determine the results and value of the behavior change interventions. This comprehensive understanding of outcomes data allows HealthMedia
'/>"/>

SOURCE HealthMedia, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
3. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
4. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
5. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
6. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2008)...ay Someday Inform Treatments for Spinal Cord, Othe...ire-USNewswire/ -- A protein that enables,nerve ce...e in controlling,the developing nervous system. Re...ions to form among nerve cells may provide a basis...njuries to their nervous system,including spinal ...
(Date:10/8/2008)... program to evaluate TAXUS(R) Element(TM) Platinum...NATICK, Mass., Oct. 8 /- Bo...nounced that it has completed enrollment in,the PE...ird-generation,TAXUS(R) Element(TM) paclitaxel-elu...has enrolled nearly 1,500 patients at 100 U.S. and...
(Date:10/7/2008)...ct. 7 /- Prometheus Laboratories Inc....ced findings from its,development of PROMETHEUS(R)... irritable bowel syndrome (IBS). The findings sugg...rticular biomarkers in blood samples,between IBS a...iomarkers,combined with a proprietary algorithm, ...
(Date:10/7/2008)...LEXX Trial Presented at the Osteoarthritis Researc...RSIPPANY, N.J., Oct. 7 /- Ferring Pha...the FLEXX Trial of Osteoarthritis of the,Knee, sho...ighly pure,non-avian high molecular weight form of...ior to intra-articular saline (IA-saline) for the ...
Breaking Medicine Technology:Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Specific antagonism lowers blood pressure 63 1New prion protein discovered by Canadian scientists may offer insight into mad cow disease 58 1New prion protein discovered by Canadian scientists may offer insight into mad cow disease 58 2Preclinical study suggests organ transplant drug may aid in lupus fight 53 1Preclinical study suggests organ transplant drug may aid in lupus fight 53 2First biomarker discovered that predicts prostate cancer outcome 48 1First biomarker discovered that predicts prostate cancer outcome 48 2First biomarker discovered that predicts prostate cancer outcome 48 3First biomarker discovered that predicts prostate cancer outcome 48 4
... from the ASSERT Trial Presented at EULAR, BARCELO... Data,presented today at the European League Again...Rheumatology showed that patients with,ankylosing ...mab),over two years experienced significant improv...eated patients showed sustained,reductions in spin...
...sults Published in Cancer Research, TARRYTOWN, N.Y...,Corporation today announced the results of scient...MPC-6827) is effective in treating,multiple types ...hanism by which MPC-6827 exerts its effects, and (...proteins known to be involved,in cancer drug resis...
Other Medicine Technology:Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 2Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 3Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 4Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 5Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 6Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 7Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 8Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 9Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 10Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 11Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 12New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 2New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 3New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 4New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 5New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 6
(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...ent of a transfusion-free surgical program for Jeh...tation also has helped// reduce the overall use of...oing the procedure, according to a study in the Se...one of the JAMA/Archives journals. "Orthotopic liv...
...luding registered nurses and doctors from Doctors ...d on the Contra Costa County Board of Supervisors/...ed a unanimous vote from the hospital’s board of d...ment to file for bankruptcy. Nurse Tami Roncskevit...
...e revealed that increased levels of lipoprotein(a)...r events// in healthy women according to Boston-ba...recommend generalized screening of lipoprotein(a) ...ly extremely high levels were associated with card...
...ent research, consumption of fatty fish like salmo...p in protection against kidney cancer//. A big, 1...sing on their consumption of fatty and lean fish a...concluded that those who ate great amounts of fatt...
Other Medicine News:Health News:Transfusion-Free Surgical Program Helpful for Liver Transplantation Patients 2Health News:Transfusion-Free Surgical Program Helpful for Liver Transplantation Patients 3Health News:Bankruptcy forces Hospital staff to Call For County Takeover 2Health News:Bankruptcy forces Hospital staff to Call For County Takeover 3Health News:High lipoprotein Levels in women Linked to Cardiovascular Risk 2Health News:Fatty Fish consumption may reduce Kidney Cancer risk 2Health News:Fatty Fish consumption may reduce Kidney Cancer risk 3
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: